POINT Biopharma Global Inc

NASDAQ:PNT   3:10:08 PM EDT
6.84
+0.18 (+2.70%)
Earnings Announcements

Point Biopharma Global Inc Reports Quarterly Net Loss Per Share Of $0.26

Published: 11/14/2022 13:41 GMT
POINT Biopharma Global Inc (PNT) - Point Biopharma Reports Third Quarter 2022 Financial Results and Announces Strategic Collaboration and Exclusive License Agreements With Lantheus Holdings.
Qtrly Net Loss per Share $0.26.
Q3 Earnings per Share View $-0.28 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.26

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.27

More details on our Analysts Page.